Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2011 Jan 22;6(1):10.1371/annotation/90e60d13-28ac-4eed-8104-893bead21eb7. doi: 10.1371/annotation/90e60d13-28ac-4eed-8104-893bead21eb7

Correction: A Recombinant Vaccine Effectively Induces C5a-Specific Neutralizing Antibodies and Prevents Arthritis

Kutty Selva Nandakumar, Åsa Jansson, Bingze Xu, Niclas Rydell, Parvien Ahooghalandari, Lars Hellman, Anna M Blom, Rikard Holmdahl
PMCID: PMC3279938

The authors with to add Lars Hellman and Parvin Ahooghalandari to the byline. The updated byline is: Kutty Selva Nandakumar1,2, Åsa Jansson3, Bingze Xu3, Niclas Rydell3, Parvin Ahooghalandari4, Lars Hellman4, Anna M. Blom5, Rikard Holmdahl12

The updated affiliations are: 1 Medical Inflammation Research, Department of Experimental Medicine, Lund University, Lund, Sweden, 2 Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden, 3 Resistentia Pharmaceuticals AB, Uppsala, Sweden, 4 Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden, 5 Section of Medical Protein Chemistry, Department of Laboratory Medicine, Lund University, Skåne University Hospital, Malmö, Sweden

The updated citation is: Nandakumar KS, Jansson Å, Xu B, Rydell N, Ahooghalandari P, et al. (2010) A Recombinant Vaccine Effectively Induces C5a-Specific Neutralizing Antibodies and Prevents Arthritis. PLoS ONE 5(10): e13511. doi:10.1371/journal.pone.0013511

Footnotes

Competing Interests: No competing interests declared.


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES